U.S. markets closed
  • S&P 500

    -40.76 (-0.91%)
  • Dow 30

    -166.42 (-0.48%)
  • Nasdaq

    -137.93 (-0.91%)
  • Russell 2000

    +3.96 (+0.18%)
  • Crude Oil

    -0.65 (-0.90%)
  • Gold

    -2.80 (-0.16%)
  • Silver

    -0.33 (-1.44%)

    -0.0037 (-0.32%)
  • 10-Yr Bond

    +0.0390 (+2.93%)

    -0.0063 (-0.45%)

    +0.2020 (+0.18%)

    -492.66 (-1.02%)
  • CMC Crypto 200

    -32.05 (-2.61%)
  • FTSE 100

    -63.84 (-0.91%)
  • Nikkei 225

    +176.75 (+0.58%)

General Dynamics (GD) NASSCO Wins Deal to Support DDG 91 Ships

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

General Dynamics Corp.’s GD business unit, NASSCO, recently secured a $98.7-million contract for the modernization of the USS Pinckney (DDG 91) Arleigh Burke-class missile destroyer. The contract was awarded by the Naval Sea Systems Command, Washington, D.C.. Work related to the deal will be performed in San Diego, CA, and is scheduled to be completed by July 2023. If additional options of the contract are exercised by both parties, the entire value of the same could reach $121.1 million.

Growing Importance of DDG 91 Ships

Being one of the largest military shipbuilding manufacturers in the United States, General Dynamics enjoys a dominant position in the global naval shipbuilding market. The DDG 91 ships have gained widespread importance within the U.S. Naval forces, as these warships are equipped with Lockheed Martin’s LMT Aegis Weapon System, a highly integrated naval weapon system. These missile destroyers also contain SH-60 Seahawk helicopters, and advanced anti-aircraft and land-attack missiles.

With growing demand for this warship, General Dynamics is witnessing a steady flow of contracts. Alongside General Dynamics, Huntington Ingalls HII, the largest military shipbuilding company in the United States, manufactures the DDG 91 Arleigh Burke-Class destroyer ship for the U.S. Navy.

Notably, the DDG 91 Arleigh Burke-class missile destroyers’ importance continues to grow as these ships offer a wide range of advanced warfighting capabilities in multi-threat air, surface and subsurface environments. It also offers protection against a wide range of threats, including ballistic missiles.

Future Prospects

Per a report released by the U.S. Department of Defense, the fiscal 2022 defense budget includes a spending provision of $34.6 billion on combat-effective naval forces, higher than fiscal 2021’s allotted budget of $32.3 billion. The allotted budget specifically includes the requirement of one Arleigh Burke Destroyer. Such favorable budgetary projections bode well for major shipbuilders like General Dynamics, as it increases the company’s possibility of winning more shipbuilding and associated contracts.

Further, looking ahead, the global naval shipbuilding market is expected to grow by $14.36 billion during the 2020-2024 period at a CAGR of 3%, as estimated by a Technavio report. Notably, other players in the same industry, such as Mitsubishi Heavy Industries, Ltd. MHVYF, alongside General Dynamics and Huntington Ingalls, should potentially benefit from the projected growth of the naval shipbuilding market.

Our View

General Dynamics has been serving the U.S. Navy by constructing and delivering next-generation combat ships for decades. Being one of the Navy's primary surface combatants, the DDG 91 destroyers enjoy solid demand. Such steep demand places General Dynamics at an advantageous position in the shipbuilding business.

Price Performance & Zacks Rank

Shares of General Dynamics have gained 15.3% in a year compared with the industry’s growth of 3.7%.

Zacks Investment Research
Zacks Investment Research

Image Source: Zacks Investment Research

General Dynamics currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

General Dynamics Corporation (GD) : Free Stock Analysis Report

Lockheed Martin Corporation (LMT) : Free Stock Analysis Report

Huntington Ingalls Industries, Inc. (HII) : Free Stock Analysis Report

Mitsubishi Heavy Industries, Ltd. (MHVYF) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research